{"transactions":[{"id":941894,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:35:34.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 300,000 restricted stock units on January 7, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":557805,"source":{"system":"sec-edgar","filing":"0001104659-26-002506","document":"tm262627-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926002506/tm262627-4_4seq1.xml","form_type":"4"}},{"id":978803,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-05T21:07:39.000Z","date":"2025-12-03","kind":"other","planned":false,"acquired":false,"shares":63800,"price":1.5,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":257805,"source":{"system":"sec-edgar","filing":"0001104659-25-118882","document":"tm2532693-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925118882/tm2532693-3_4seq1.xml","form_type":"4"}},{"id":1303220,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:30:15.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":169500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":169500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":169500},"source":{"system":"sec-edgar","filing":"0001104659-25-003494","document":"tm253166-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003494/tm253166-1_4seq1.xml","form_type":"4"}},{"id":1303219,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-01-14T22:30:15.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":81300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person received an award of 81,300 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":309628,"source":{"system":"sec-edgar","filing":"0001104659-25-003494","document":"tm253166-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003494/tm253166-1_4seq1.xml","form_type":"4"}},{"id":1303218,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-01-14T22:30:15.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":113000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 113,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":228328,"source":{"system":"sec-edgar","filing":"0001104659-25-003494","document":"tm253166-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003494/tm253166-1_4seq1.xml","form_type":"4"}},{"id":1341390,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-12-05T22:06:19.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":false,"shares":8256,"price":1.13,"value":9329.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":115328,"source":{"system":"sec-edgar","filing":"0001104659-24-125944","document":"tm2430303-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924125944/tm2430303-3_4seq1.xml","form_type":"4"}},{"id":4382035,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Options to purchase common stock","published_at":"2017-03-16T20:07:49.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":75000,"price":1.39,"value":104250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":1.39,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-17-002450","document":"f4031417cicic_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017002450/f4031417cicic_actinium.xml","form_type":"4"}}]}